ECSP17016755A - ANTI TIGIT ANTIBODIES - Google Patents
ANTI TIGIT ANTIBODIESInfo
- Publication number
- ECSP17016755A ECSP17016755A ECIEPI201716755A ECPI201716755A ECSP17016755A EC SP17016755 A ECSP17016755 A EC SP17016755A EC IEPI201716755 A ECIEPI201716755 A EC IEPI201716755A EC PI201716755 A ECPI201716755 A EC PI201716755A EC SP17016755 A ECSP17016755 A EC SP17016755A
- Authority
- EC
- Ecuador
- Prior art keywords
- tigit antibodies
- anti tigit
- antibodies
- cancer
- diseases
- Prior art date
Links
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 title 1
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a anticuerpos anti TIGIT, así como al uso de estos anticuerpos en el tratamiento de enfermedades tales como cáncer y enfermedad infecciosa.The present invention relates to anti-TIGIT antibodies, as well as the use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462038912P | 2014-08-19 | 2014-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP17016755A true ECSP17016755A (en) | 2017-03-31 |
Family
ID=58694403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201716755A ECSP17016755A (en) | 2014-08-19 | 2017-03-17 | ANTI TIGIT ANTIBODIES |
Country Status (2)
| Country | Link |
|---|---|
| AR (2) | AR101565A1 (en) |
| EC (1) | ECSP17016755A (en) |
-
2015
- 2015-08-14 AR ARP150102630A patent/AR101565A1/en active IP Right Grant
-
2017
- 2017-03-17 EC ECIEPI201716755A patent/ECSP17016755A/en unknown
-
2020
- 2020-09-29 AR ARP200102706A patent/AR120118A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR101565A1 (en) | 2016-12-28 |
| AR120118A2 (en) | 2022-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017001561A2 (en) | Anti tigit antibodies | |
| ECSP19020740A (en) | ANTI-CD27 ANTIBODIES | |
| MX2023014569A (en) | ANTI-SIRPA ANTIBODIES. | |
| MX2017006283A (en) | USEFUL MACROCICLIC PEPTIDES AS IMMUNOMODULATORS. | |
| CL2016002455A1 (en) | Multispecific antibodies. | |
| PH12015501071A1 (en) | Combination therapy of anti-her3 antibodies | |
| CL2017000053A1 (en) | Β-protofibril binding antibodies | |
| CO2017005566A2 (en) | Cyclic peptides derived from cd44v6 for the treatment of diseases related to cancers and angiogenesis | |
| AR120118A2 (en) | ANTI-TIGIT ANTIBODIES | |
| AR111715A1 (en) | ANTI-SIRPa ANTIBODIES | |
| EA202091619A3 (en) | ANTIBODIES AGAINST TIGIT | |
| UA104459U (en) | The use of lactoproteinum with sorbitol as tsytoprotektora adenohypophysis at burn disease. |